Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images—reference values and performance in patients with heart failure and left ventricular hypertrophy
- 6 February 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal – Cardiovascular Imaging
- Vol. 18 (12), 1414-1422
- https://doi.org/10.1093/ehjci/jew324
Abstract
Left ventricular hypertrophy (LVH) has strong prognostic implications and is associated with heart failure. Recently, myocardial contraction fraction (MCF) was identified as a useful marker for specifically identifying cardiac amyloidosis (CA). The purpose of this study was to evaluate the diagnostic accuracy of MCF for the discrimination of different forms of LVH. We analysed cardiovascular magnetic resonance (CMR) scans of patients with CA (n = 132), hypertrophic cardiomyopathy (HCM, n = 60), hypertensive heart disease (HHD, n = 38) and in 100 age- and gender-matched healthy controls. MCF was calculated by dividing left ventricular (LV) stroke volume by LV myocardial volume. The diagnostic accuracy of MCF was compared to that of LV ejection fraction (EF) and the mass index (MI). Compared with controls (136.3 ± 24.4%, P < 0.05), mean values for MCF were significantly reduced in LVH (HHD:92.6 ± 20%, HCM:80 ± 20.3%, transthyretin CA:74.9 ± 32.2% and light-chain (AL) CA:50.5 ± 21.4%). MCF performed better than LVEF (AUC = 0.96 vs. AUC = 0.6, P < 0.001) and was comparable to LVMI (AUC = 0.95, P = 0.4) in discriminating LVH from controls. There was a significant yet weak correlation between MCF and LVEF (r = 0.43, P < 0.0001). MCF outperformed LVEF and LVMI in discriminating between different etiologies of LVH and between AL and other forms of LVH (AUC = 0.84, P < 0.0001). Moreover, cut-off values for MCF <50% and LVEF <60% allowed to identify patients with high probability for CA. In patients with heart failure MCF discriminates CA from other forms of LVH. As it can easily be derived from standard, non-contrast cine images, it may be a very useful marker in the diagnostic workup of patients with LVH.Keywords
This publication has 24 references indexed in Scilit:
- Increased Extracellular Volume and Altered Mechanics Are Associated With LVH in Hypertensive Heart Disease, Not Hypertension AloneJACC: Cardiovascular Imaging, 2015
- Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imagingAmyloid, 2014
- The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosisAmyloid, 2014
- T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular HypertrophyCirculation: Cardiovascular Imaging, 2013
- Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statementJournal of Cardiovascular Magnetic Resonance, 2013
- Prognosis Assessment of Cardiac Involvement in Systemic AL Amyloidosis by Magnetic Resonance ImagingAmerican Journal Of Medicine, 2010
- The Current and Emerging Role of Cardiovascular Magnetic Resonance Imaging in Hypertrophic CardiomyopathyJournal of Cardiovascular Translational Research, 2009
- Operator Induced Variability in Left Ventricular Measurements with Cardiovascular Magnetic Resonance is Improved After TrainingJournal of Cardiovascular Magnetic Resonance, 2007
- Cardiovascular Magnetic Resonance in Cardiac AmyloidosisCirculation, 2005
- Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 casesBlood, 1986